Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Clinical trial NCT04430699 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04430699
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2026-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.